Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel
· Delayed Price · Currency is ILS · Price in ILA 30.30
-1.50 (-4.72%)
Jun 18, 2025, 5:24 PM IDT
TLV:CBI Market Cap
TLV:CBI has a market cap or net worth of 47.52 million as of June 20, 2025. Its market cap has decreased by -30.66% in one year.
Market Cap
47.52M
Enterprise Value
72.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.30
Market Cap Chart
Since July 23, 2007, TLV:CBI's market cap has decreased from 797.05M to 47.52M, a decrease of -94.04%. That is a compound annual growth rate of -14.56%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 68.00B |
| Danel (Adir Yeoshua) | 2.55B |
| Kamada | 1.46B |
| Bait Bakfar | 1.06B |
| BrainsWay | 722.92M |
| Novolog (Pharm-Up 1966) | 722.84M |
| SofWave Medical | 711.69M |
| Ilex Medical | 691.87M |